Day: August 6, 2020

Šiaulių Bankas AB (hereinafter referred to as the Bank), company code 112025254, domicile address Tilžės st. 149, Šiauliai, Lithuania.During the Investor Conference Webinar Vytautas Sinius, CEO and Donatas Savickas, CFO introduced the Bank’s financial results for the first half of the year 2020 and answered the participant questions aftewards.The live coverage was followed by more than 40 participants, recording of the investor webinar (in English) is available there.Presentation of the webinar (in English): https://sb.lt/uploads/media/5f2b9b57b0603/sab-investor-webinar-q2-2020.pdf?token=/uploads/media/5f2b9b57b0603/sab-investor-webinar-q2-2020.pdfŠiaulių Bankas thanks all participants.Additional information:Tomas VarenbergasHead of Treasury and Marketstomas.varenbergas@sb.lt, +370 5 203 22 00

AB Šiaulių bankas (toliau – Bankas), įmonės kodas 112025254, buveinės adresas: Tilžės g. 149, Šiauliai, Lietuva.Internetiniame seminare Banko administracijos vadovas Vytautas Sinius bei Finansų ir rizikos valdymo tarnybos vadovas Donatas Savickas komentavo Banko 2020 metų pirmojo pusmečio finansinius veiklos rezultatus bei aktualijas ir po pristatymo atsakė į dalyvių klausimus.Seminarą sekė daugiau kaip 40 dalyvių, internetinio seminaro įrašą (anglų kalba) galima rasti čiaPristatymas (anglų kalba): https://sb.lt/uploads/media/5f2b9b57b0603/sab-investor-webinar-q2-2020.pdf?token=/uploads/media/5f2b9b57b0603/sab-investor-webinar-q2-2020.pdfBankas dėkoja seminaro dalyviams.Papildoma informacija:Tomas VarenbergasRinkų ir iždo departamento direktoriustomas.varenbergas@sb.lt, +370 5 203 22 00

                                                                                                                                                 Second quarter in briefDr Elaine Sullivan, Dr Aleksandar Danilovski and Dr Axel Glasmacher were appointed as new members of the Board at the Annual General Meeting on May 19Active Biotech provided status update in the portfolio projectsNew preclinical data on tasquinimod’s effects in experimental models for multiple myeloma were presented at the Virtual Edition of the 25th European Hematology Association Annual Congress Meeting in June                   Events after the end of the period            ·First patient dosed in the phase 1b/2a study of tasquinimod use in treatment of multiple myelomaFinancial summaryFor further information, please contact:The report is also available at www.activebiotech.com.This...

                                                                                                                                                  Kvartal 2 i korthetDr Elaine Sullivan, Dr Aleksandar Danilovski och Dr Axel Glasmacher, utsågs till nya styrelseledamöter vid årsstämman den 19 majActive Biotech tillhandahöll statusuppdatering i portföljprojektenNya prekliniska data med tasquinimod i experimentella modeller för multipel myelom presenterades på den virtuella versionen av 25th European Hematology Association Annual Congress Meeting i juniHändelser efter periodens utgång            ·Första patienten har doserats i fas 1b/2a-studien med tasquinimod vid behandling av multipelt myelomEkonomisk översiktFör ytterligare information, vänligen kontakta:Rapporten finns även tillgänglig på www.activebiotech.com.Denna information är sådan...

In the second quarter (1 April – 30 June) of the 2020 financial year, Tallink Grupp AS and its subsidiaries (the Group) carried 388 thousand passengers, which is 85.4% less than in the second quarter last year. The number of cargo units transported decreased by 12.8% in the same comparison. The Group’s unaudited consolidated revenue decreased by 74.6% or EUR 191.1 million to a total of EUR 65.0 million. Unaudited EBITDA was EUR 2.4 million (EUR 50.7 million in Q2 2019) and unaudited net loss was EUR 27.4 million (net profit of EUR 14.9 million in Q2 2019).In the second quarter, the Group’s revenue and operating results were impacted by the following operational factors:Covid-19 and related travel restrictions.978 trips less due to suspended operations.Restrictions on maximum capacity.Impact of Covid-19 and travel restrictionsDue to the...

Tallink Grupp AS ja tema tütarettevõtted (edaspidi “kontsern“) vedas 2020. aasta teises kvartalis 388 tuhat reisijat, mida on 85,4% võrra vähem kui eelmise aasta teises kvartalis. Veetud kaubaveoühikute arv langes eelmise aastaga võrreldes 12,8% võrra. Kontserni auditeerimata müügitulu langes 74,6% ehk 191,1 miljoni euro võrra 65,0 miljoni euroni. Auditeerimata kulumieelne ärikasum (EBITDA) oli 2,4 miljonit eurot (2019. aasta teises kvartalis 50,7 miljonit eurot) ja auditeerimata puhaskahjum 27,4 miljonit eurot (2019. aasta teise kvartali puhaskasum oli 14,9 miljonit eurot).Teises kvartalis mõjutasid kontserni müügitulu ja majandustulemust järgmised äritegevusega seotud tegurid:Covid-19 ja sellega seotud reisipiirangud;tegevuse ajutise peatamise tõttu 978 võrra vähenenud reiside arv;maksimaalset täituvust sätestavad piirangud.Koroonaviiruse...

GENEVA, Aug. 06, 2020 (GLOBE NEWSWIRE) — Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), an  independent renewable power producer, released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and six months ended June 30, 2020.Etrion delivered steady project-level results in the second quarter of 2020 from its Japanese assets. The optimization of the Japanese corporate structure and renegotiation of the operations and maintenance (“O&M”) contracts partially offset the impact of lower solar irradiation levels compared to the same period in 2019.Q2-20 HIGHLIGHTSOperationalEtrion produced 20.5 Gigawatt-hours (“GWh”) of electricity from the Company’s 57-megawatt (“MW”) portfolio comprising 11 solar power plant sites in Japan....

If you are looking for funds for your personal or professional needs, you can apply for a loan against car. Also known as a secured loan, it has low-interest rate and flexible repayment tenure. The biggest advantage of the loan is that you can use the funds where you wish to. One of the most reliable lenders in the country, Hero FinCorp will ensure that the process of loan application and approval is quick and efficient. Hero FinCorp has a strong presence across every part of the country. They strive to help individuals meet their personal and professionals needs and they have worked with several individuals over the years. One of the most trusted and sought after lenders, Hero FinCorp will help you throughout the process and will ensure that the loan is approved in no time. The loan has a simple and transparent application procedure. A...

Major stocks ended the day propitiously high after investors are still focus on fresh signs of corporate earnings report and government’s stimulus package with the hope that it will relieve them from the coronavirus pandemic stress. The Dow has impressively pulled today’s session higher with Apple as the main contributor after bagging almost 0.7% gained. Netflix also advanced 2.21% setting Nasdaq higher just before the day ends. Under commodities, Gold outperformed its previous price hitting another record high, marking its first above 2000 price this year. Here are the main movements in the Global Market this Tuesday;Stocks– The Dow Jones Industrial Average jumps big time with 164.07 points or 0.62% to 26,828.47.– S&P 500 advances with 12 points, or 0.36% gained to 3,306.51 as market closed.– Nasdaq Composite has...

AB Ignitis Grupė, (hereinafter – the Company) identification code 301844044, registered office placed at Žvejų str. 14, Vilnius, Republic of Lithuania. The total nominal value of issued bonds 900 000 000 EUR; ISIN codes XS1646530565; XS1853999313; XS2177349912.The Company decided that the minority shareholders of its subsidiaries AB Ignitis gamyba (hereinafter – Ignitis gamyba, GEN) and AB Energijos skirstymo operatorius (hereinafter – ESO), who comply with the settlement agreement (hereinafter – the Agreement) of 17 March 2020, will retain the privilege to acquire the shares of Ignitis Group during the initial public offering of the Company’s shares.In the company’s view, the actions of one shareholder of Ignitis Gamyba should not affect all minority shareholders who comply with the Agreement.AB Ignitis...